Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trialByeong-Ho Park, David H. Kirn, Jae‐Seok Kim et al.|The Lancet Oncology|2008Cited by 522
Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activityCarolina S. Ilkow, John C. Bell|Nature Medicine|2015Cited by 167
Surgical Stress Promotes the Development of Cancer Metastases by a Coagulation-Dependent Mechanism Involving Natural Killer Cells in a Murine ModelRashmi Seth, Rebecca C. Auer, Lee‐Hwa Tai et al.|Annals of Surgery|2012Cited by 123
Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatmentMarie‐Claude Bourgeois‐Daigneault, John C. Bell|Breast Cancer Research|2016Cited by 84
CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOXJack T. Whelan, John C. Bell|Frontiers in Immunology|2023Cited by 13